2021
Another Reason for Greater Transparency at the US Food and Drug Administration
Steinbrook R. Another Reason for Greater Transparency at the US Food and Drug Administration. JAMA Internal Medicine 2021, 181: 529-529. PMID: 33587096, DOI: 10.1001/jamainternmed.2020.8841.Peer-Reviewed Original Research
2020
Lobbying Expenditures, Campaign Contributions, and Health Care—Follow the Money
Steinbrook R. Lobbying Expenditures, Campaign Contributions, and Health Care—Follow the Money. JAMA Internal Medicine 2020, 180: 640-642. PMID: 32125363, DOI: 10.1001/jamainternmed.2020.0145.Peer-Reviewed Original ResearchDecreasing Medicare Spending on Prescription Drugs
Steinbrook R. Decreasing Medicare Spending on Prescription Drugs. JAMA Internal Medicine 2020, 180: 601-601. PMID: 32011621, DOI: 10.1001/jamainternmed.2019.7064.Peer-Reviewed Original Research